Evidence mounts for anti-CGRP treatment in cluster headache

Research output: Contribution to journalArticlepeer-review


During cluster headache attacks, plasma levels of calcitonin gene-related peptide (CGRP) increase, and trigeminal nerve activation leads to pain. A new study shows that CGRP infusion can induce cluster headache attacks in some patients, with important implications for the investigation of CGRP-targeted therapies in cluster headache.

Original languageEnglish
JournalNature Reviews Neurology
Publication statusAccepted/In press - Jan 1 2018

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Evidence mounts for anti-CGRP treatment in cluster headache'. Together they form a unique fingerprint.

Cite this